首页> 外文期刊>Journal of Neural Transmission >Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade
【24h】

Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade

机译:氯氮平对社交行为障碍的挽救和GRPR阻断所致大鼠神经发育障碍模型中神经元受体表达的改变

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have previously shown that pharmacological blockade of the gastrin-releasing peptide receptor (GRPR) during the neonatal period in rats produces behavioral features of developmental neuropsychiatric disorders. Here, we show that social interaction deficits in this model are reversed by the atypical antipsychotic clozapine given in the adulthood. In addition, we analyzed the mRNA expression of three neuronal receptors potentially involved in the etiology of disorders of the autism spectrum. Rats were injected with the GRPR antagonist RC-3095 or saline (SAL) from postnatal days 1–10, and tested for social behavior and recognition memory in the adulthood. One hour prior to the behavioral testing, rats were given a systemic injection of clozapine or saline. The mRNA expression of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor, the epidermal growth factor receptor (EGFR), and GRPR was measured in the hippocampus and cortex of a separate set of rats given RC-3095 or SAL neonatally. Rats given neonatal RC-3095 showed decreased social interaction and impaired object recognition memory. Clozapine rescued the social interaction impairment. Neonatal treatment with RC-3095 also resulted in dose-dependent decreases in the expression of GRPR, NR1, and EGFR in the cortex, whereas all three receptor mRNAs were increased in the hippocampus in rats treated with the lower dose of RC-3095. The results contribute to further validate the novel rat model of neurodevelopmental disorders induced by GRPR blockade, and shows alterations in the expression of neuronal receptors in this model.
机译:以前我们已经表明,在大鼠的新生阶段,胃泌素释放肽受体(GRPR)的药理学阻断作用产生了发育性神经精神疾病的行为特征。在这里,我们表明,在成年期使用非典型抗精神病药物氯氮平可以逆转这种模型中的社交互动障碍。此外,我们分析了自闭症谱系障碍的病因中可能涉及的三种神经元受体的mRNA表达。从出生后1-10天开始,向大鼠注射GRPR拮抗剂RC-3095或生理盐水(SAL),并测试其成年后的社交行为和识别记忆。在行为测试前一小时,给大鼠全身注射氯氮平或生理盐水。在另一组给予RC-3095或RC-3095的大鼠的海马和皮层中测量了N-甲基-D-天冬氨酸(NMDA)受体,表皮生长因子受体(EGFR)和GRPR的NR1亚基的mRNA表达。 SAL新生儿。给予新生儿RC-3095的大鼠表现出减少的社交互动和受损的物体识别记忆。氯氮平挽救了社会交往障碍。 RC-3095新生儿治疗还导致了皮质中GRPR,NR1和EGFR表达的剂量依赖性降低,而用较低剂量RC-3095治疗的大鼠海马中所有三个受体mRNA均升高。该结果有助于进一步验证由GRPR阻断诱导的新型大鼠神经发育障碍模型,并显示该模型中神经元受体表达的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号